Advertisement
Canada markets open in 2 hours 23 minutes

  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CAD/USD

    0.7307
    -0.0013 (-0.18%)
     

  • CRUDE OIL

    82.77
    -0.59 (-0.71%)
     

  • Bitcoin CAD

    90,949.95
    +462.65 (+0.51%)
     

  • CMC Crypto 200

    1,433.05
    +8.95 (+0.63%)
     

  • GOLD FUTURES

    2,329.60
    -12.50 (-0.53%)
     

  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • NASDAQ futures

    17,699.75
    +93.00 (+0.53%)
     

  • VOLATILITY

    15.85
    +0.16 (+1.02%)
     

  • FTSE

    8,089.74
    +44.93 (+0.56%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6834
    -0.0002 (-0.03%)
     

Valeant won't pay whatever it takes for Allergan: CEO

Reuters

(Reuters) - Valeant Pharmaceuticals Inc won't pay whatever it takes to acquire rival Allergan Inc, and it will not turn its bid into an all-cash deal, Valeant Chief Executive Michael Pearson said on Tuesday in New York. Valeant and activist investor Bill Ackman made an unsolicited $47 billion bid to buy Botox maker Allergan as it seeks to become one of the world's five biggest drug companies. (Reporting by Bill Berkrot in New York; Writing by Rod Nickel in Winnipeg, Manitoba; Editing by Meredith Mazzilli)